<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2023, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 11 Dec 2023 17:41:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Spyre Therapeutics, Inc.  For: Dec 07  Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07++Filed+by%3A+Fairmount+Funds+Management+LLC/22514761.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07++Filed+by%3A+Fairmount+Funds+Management+LLC/22514761.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07++Filed+by%3A+Fairmount+Funds+Management+LLC/22514761.html</guid>
   <pubDate>Mon, 11 Dec 2023 17:41:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  4          Spyre Therapeutics, Inc.  For: Dec 07  Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07++Filed+by%3A+Fairmount+Funds+Management+LLC/22514761.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07++Filed+by%3A+Fairmount+Funds+Management+LLC/22514761.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07++Filed+by%3A+Fairmount+Funds+Management+LLC/22514761.html</guid>
   <pubDate>Mon, 11 Dec 2023 17:41:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   Spyre Therapeutics, Inc.               Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22514652.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22514652.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22514652.html</guid>
   <pubDate>Mon, 11 Dec 2023 17:22:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   Spyre Therapeutics, Inc.               Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22514652.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22514652.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22514652.html</guid>
   <pubDate>Mon, 11 Dec 2023 17:22:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  4/A        Spyre Therapeutics, Inc.  For: Nov 22  Filed by: Albers Jeffrey W.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508571.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508571.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508571.html</guid>
   <pubDate>Fri, 08 Dec 2023 16:08:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  4/A        Spyre Therapeutics, Inc.  For: Nov 22  Filed by: Albers Jeffrey W.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508571.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508571.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508571.html</guid>
   <pubDate>Fri, 08 Dec 2023 16:08:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  424B3      Spyre Therapeutics, Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22508543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22508543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22508543.html</guid>
   <pubDate>Fri, 08 Dec 2023 16:07:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  424B3      Spyre Therapeutics, Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22508543.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22508543.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22508543.html</guid>
   <pubDate>Fri, 08 Dec 2023 16:07:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  3/A        Spyre Therapeutics, Inc.  For: Nov 22  Filed by: Albers Jeffrey W.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508457.html</guid>
   <pubDate>Fri, 08 Dec 2023 16:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  3/A        Spyre Therapeutics, Inc.  For: Nov 22  Filed by: Albers Jeffrey W.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3A++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+22++Filed+by%3A+Albers+Jeffrey+W./22508457.html</guid>
   <pubDate>Fri, 08 Dec 2023 16:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  8-K        Spyre Therapeutics, Inc.  For: Dec 07</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07/22506756.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07/22506756.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07/22506756.html</guid>
   <pubDate>Fri, 08 Dec 2023 08:46:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  8-K        Spyre Therapeutics, Inc.  For: Dec 07</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07/22506756.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07/22506756.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Dec+07/22506756.html</guid>
   <pubDate>Fri, 08 Dec 2023 08:46:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Spyre Therapeutics Announces $180 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</guid>
   <pubDate>Thu, 07 Dec 2023 18:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYRE</category>
   	  </item>
  <item>
   <title>Spyre Therapeutics Announces $180 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</guid>
   <pubDate>Thu, 07 Dec 2023 18:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYRE</category>
   	  </item>
  <item>
   <title>Spyre Therapeutics Announces $180 Million Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</guid>
   <pubDate>Thu, 07 Dec 2023 18:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYRE</category>
   	  </item>
  <item>
   <title>Spyre Therapeutics Announces $180 Million Private Placement</title>
   <link>http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</guid>
   <pubDate>Thu, 07 Dec 2023 18:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYRE</category>
   	  </item>
  <item>
   <title>Spyre Therapeutics Announces $180 Million Private Placement</title>
   <link>http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</guid>
   <pubDate>Thu, 07 Dec 2023 18:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYRE</category>
   	  </item>
  <item>
   <title>Spyre Therapeutics Announces $180 Million Private Placement</title>
   <link>http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Spyre+Therapeutics+Announces+%24180+Million+Private+Placement/22505251.html</guid>
   <pubDate>Thu, 07 Dec 2023 18:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYRE</category>
   	  </item>
  <item>
   <title>Form  SC 13G     Spyre Therapeutics, Inc.               Filed by: COMMODORE CAPITAL LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+COMMODORE+CAPITAL+LP/22481513.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+COMMODORE+CAPITAL+LP/22481513.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+COMMODORE+CAPITAL+LP/22481513.html</guid>
   <pubDate>Fri, 01 Dec 2023 16:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  SC 13G     Spyre Therapeutics, Inc.               Filed by: COMMODORE CAPITAL LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+COMMODORE+CAPITAL+LP/22481513.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+COMMODORE+CAPITAL+LP/22481513.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+COMMODORE+CAPITAL+LP/22481513.html</guid>
   <pubDate>Fri, 01 Dec 2023 16:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  424B3      Spyre Therapeutics, Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22477242.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22477242.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22477242.html</guid>
   <pubDate>Thu, 30 Nov 2023 17:19:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  424B3      Spyre Therapeutics, Inc.             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22477242.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22477242.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Spyre+Therapeutics%2C+Inc.+++++++++++++/22477242.html</guid>
   <pubDate>Thu, 30 Nov 2023 17:19:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   Spyre Therapeutics, Inc.               Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22471396.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22471396.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22471396.html</guid>
   <pubDate>Wed, 29 Nov 2023 17:09:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   Spyre Therapeutics, Inc.               Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22471396.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22471396.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Spyre+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Fairmount+Funds+Management+LLC/22471396.html</guid>
   <pubDate>Wed, 29 Nov 2023 17:09:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
  <item>
   <title>Form  4          Spyre Therapeutics, Inc.  For: Nov 24  Filed by: Fairmount Funds Management LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+24++Filed+by%3A+Fairmount+Funds+Management+LLC/22463972.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+24++Filed+by%3A+Fairmount+Funds+Management+LLC/22463972.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Spyre+Therapeutics%2C+Inc.++For%3A+Nov+24++Filed+by%3A+Fairmount+Funds+Management+LLC/22463972.html</guid>
   <pubDate>Tue, 28 Nov 2023 16:06:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGLE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25515888</category>
   	  </item>
 </channel>
</rss>
